S1RP34:BVMF
Sarepta Therapeutics Bdr
R$4.77
arrow_upward
+0.42%(+0.020) 1D
Aug 13, 4:56:00 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for S1RP34...
Open
R$4.80
High
R$4.85
Low
R$4.76
Mkt. cap
1.95B
Avg. vol.
2.07K
Volume
0.00
52-wk high
R$6.67
52-wk low
R$3.75
Shares outstanding
105.63M
No. of employees
835
Open
R$4.80
High
R$4.85
Low
R$4.76
Mkt. cap
1.95B
Avg. vol.
2.07K
Volume
0.00
52-wk high
R$6.67
52-wk low
R$3.75
Shares outstanding
105.63M
No. of employees
835
News stories
From web sources and news partners
Simply Wall Street
·
9 hours ago
Sarepta Therapeutics (SRPT) Tightened 2026 Revenue Guidance, Is The Stock Still A Bargain?
MarketBeat
·
21 hours ago
Bank of America Corp DE Increases Stock Position in Sarepta Therapeutics, Inc. $SRPT
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Bdr
AI content may include mistakes. Learn more